INS and polycystic ovary syndrome: In 1999, Nestler et al. were the first to report DCI efficacy in the treatment of obese PCOS women for 6–8 weeks, demonstrating improved insulin sensitivity, ovulatory function, and hyperandrogenism and decreased blood pressure levels and plasma TG concentrations [94].